Edition:
United States

Inovio Pharmaceuticals Inc (INO.O)

INO.O on Nasdaq

2.37USD
16 Aug 2019
Change (% chg)

$0.18 (+8.22%)
Prev Close
$2.19
Open
$2.22
Day's High
$2.39
Day's Low
$2.21
Volume
506,449
Avg. Vol
952,381
52-wk High
$6.30
52-wk Low
$2.15

About

Inovio Pharmaceuticals, Inc. (Inovio) is a clinical-stage pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery... (more)

Overall

Beta: 2.01
Market Cap(Mil.): $273.51
Shares Outstanding(Mil.): 98.03
Dividend: --
Yield (%): --

Financials

  INO.O Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.99 -- --
ROI: -66.39 7.52 12.69
ROE: -98.31 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates